Ventures
Browse a selection of current and former i-lab ventures.
-
All
39
-
Harvard Business School
14
-
Harvard College
5
-
Harvard Faculty of Arts and Sciences
1
-
Harvard Graduate School of Arts and Sciences
3
-
Harvard John A. Paulson School of Engineering and Applied Sciences
4
-
Harvard Kennedy School
1
-
Harvard Kenneth C. Griffin Graduate School of Arts and Sciences
2
-
Harvard Medical School
19
-
Harvard School of Dental Medicine
1
-
Harvard T.H. Chan School of Public Health
4
-
Harvard University
2
-
Non-Harvard Affiliate
3
-
All
62
-
Aid and Relief
1
-
Biotech and Life Sciences
19
-
Childhood Development
1
-
Digital Health
6
-
Energy, Oil, and Renewables
1
-
Finance and Insurance
1
-
Healthcare Delivery
8
-
Medical Devices and Hardware
12
-
Mental Health
2
-
Personal Health, Wellness, and Sports
1
-
Public Health and Global Health
1
-
Software/App
4
-
Therapeutics
1
-
AbscoTx
AbscoTx injects image-guided therapy into tumors to educate the immune system to fight cancer locally and at metastatic sites.
![Absco team]()
-
Alvus Health INC
Alvus Health is developing a data-centric and automatic platform for target identification and drug discovery.
-
Aperture Bio
Realizing orders-of-magnitude improvements in speed and sensitivity, Aperture rapidly analyzes proteins in whole cells to map immune interactions.
![Aperture Bio team]()
-
Breaking
Using synthetic biology to get rid of plastic waste.
![Breaking team]()
-
CartaBio Inc
A single-cell precision medicine techbio that uses proprietary spatial biology and AI to decode novel disease biology.
![]()
-
Cellforma
Developing life-saving, first-of-its-kind regenerative cell therapies to overcome the unmet need for donor lungs.
![Cellforma cofounders]()
-
Day Zero Diagnostics
Developing technologies to help control healthcare-associated infections (HAIs), where antibiotic resistant organisms can be especially dangerous.
![Day Zero team]()
-
GC Therapeutics
Using synthetic biology to program stem cells into any cell type with best-in-class efficiency, speed, and scalability.
![GC Therapeutics co-founders]()
-
InGel Therapeutics
Regenerative cell-therapy biotech aiming to treat people affected by blindness.
![InGel team]()
-
Kinnos
Adding color to disinfectants, visualizing surface coverage for more effective and efficient cleaning in healthcare settings.
-
Lybra Bio
Developing innovative therapeutic platforms to treat Autoimmune skin diseases.
-
Manifold Bio
Designing tissue-specific medicines in living systems from the start by combining high-throughput in-vivo studies with AI-guided protein design.
![Manifold team]()
-
NuCyRNA Therapeutics
Redefining RNA-targeting therapeutics, starting in neurodegenerative diseases.
![Nucyrna team lead]()
-
Procure Bio
Engineering protein nanoparticles for targeted delivery of gene and protein therapeutics, advancing novel treatments for genetic diseases.
-
Promakhos Therapeutics
Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.
![]()
-
Radiate Biosciences
Redefining colorectal cancer screening with a blood test that delivers colonoscopy-level performance.
![]()
-
Tectonic Therapeutic, Inc.
Transforming the discovery of novel drugs addressing targets in the GPCR family.
![Tectonic team]()
-
Transcera
Transforming chronic disease treatment through improved biologic drug delivery.
-
Veri Nano
A bionanotechnology company developing antimicrobial materials and nanoparticle delivery systems for human and animal health.
